Old Web
English
Sign In
Acemap
>
authorDetail
>
Yingru Xing
Yingru Xing
Anhui University of Science and Technology
Apoptosis
Cancer research
Cell cycle
PI3K/AKT/mTOR pathway
Protein kinase B
4
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair.
2021
PLOS ONE
Yinghai Xie
Changwei Liu
Yinci Zhang
Amin Li
Chong Sun
Rui Li
Yingru Xing
Minghong Shi
Qi Wang
Show All
Source
Cite
Save
Citations (0)
PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.
2019
American Journal of Translational Research
Yinci Zhang
Chunmei Xie
Amin Li
Xueke Liu
Yingru Xing
Jing Shen
Zhen Huo
Shuping Zhou
Xinkuang Liu
Yinghai Xie
Weiya Cao
Yongfang Ma
Ruyue Xu
Shiyu Cai
Xiaolong Tang
Dong Ma
Show All
Source
Cite
Save
Citations (20)
BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway
2019
American Journal of Translational Research
Xueke Liu
Chunmei Xie
Amin Li
Yinci Zhang
Xinkuang Liu
Shuping Zhou
Jing Shen
Zhen Huo
Weiya Cao
Yongfang Ma
Ruyue Xu
Yingru Xing
Yinghai Xie
Shuyu Cai
Xiaolong Tang
Show All
Source
Cite
Save
Citations (10)
1